Paul V. Radspinner

Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI.

Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI.

Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI.

Founded in 1987, BioForward is a member-driven state association and venture capital investor located in Madison, Wisconsin. The firm serves as the voice of Wisconsin's bioscience industry. They advocate on their members behalf to create investment and partnership opportunities, attract and retain the best people and support public policy that fosters their continued growth. BioForward also provides member-support services including networking opportunities through a variety of conferences and events, online resources and group purchasing programs. Their members include bioscience companies, universities, non-profit organizations, service providers, as well as state, regional and local government representatives. BioForward was previously known as the Wisconsin Biotechnology & Medical Device Association.